X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (44) 44
humans (42) 42
oncology (38) 38
male (29) 29
female (26) 26
aged (25) 25
respiratory system (24) 24
middle aged (23) 23
cancer (22) 22
lung cancer (22) 22
chemotherapy (19) 19
adult (17) 17
lung neoplasms - drug therapy (16) 16
life sciences (15) 15
mesothelioma (15) 15
lung neoplasms - pathology (14) 14
open-label (12) 12
prognosis (12) 12
carcinoma, non-small-cell lung - drug therapy (11) 11
survival (11) 11
hematology, oncology and palliative medicine (10) 10
non-small cell lung cancer (10) 10
treatment outcome (10) 10
aged, 80 and over (8) 8
carcinoma, non-small-cell lung - pathology (8) 8
multicenter (8) 8
trial (8) 8
[sdv]life sciences [q-bio] (7) 7
care and treatment (7) 7
cisplatin (7) 7
mesothelioma - pathology (7) 7
prospective studies (7) 7
1st-line treatment (6) 6
combination (6) 6
diagnosis (6) 6
double-blind (6) 6
france (6) 6
lung cancer, non-small cell (6) 6
lung neoplasms - mortality (6) 6
neoplasm staging (6) 6
research (6) 6
risk factors (6) 6
survival analysis (6) 6
therapy (6) 6
animals (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
bevacizumab (5) 5
biomarkers (5) 5
cell lung-cancer (5) 5
clinical trials (5) 5
endothelial growth-factor (5) 5
lung neoplasms - diagnosis (5) 5
lung neoplasms - genetics (5) 5
lung neoplasms - therapy (5) 5
lung-cancer (5) 5
management (5) 5
medical prognosis (5) 5
mesothelioma - drug therapy (5) 5
metastasis (5) 5
mutation (5) 5
patients (5) 5
phase-ii trial (5) 5
pleural neoplasms - pathology (5) 5
pulmonary/respiratory (5) 5
surveys and questionnaires (5) 5
targeted therapy (5) 5
[sdv.can]life sciences [q-bio]/cancer (4) 4
adenocarcinoma (4) 4
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic agents - therapeutic use (4) 4
apoptosis (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
cisplatin - administration & dosage (4) 4
clinical trials as topic (4) 4
disease-free survival (4) 4
diseases of the respiratory system (4) 4
docetaxel (4) 4
drug therapy (4) 4
egfr (4) 4
gemcitabine (4) 4
growth-factor receptor (4) 4
guidelines (4) 4
health aspects (4) 4
histology (4) 4
internal medicine (4) 4
medicine & public health (4) 4
non-small-cell lung cancer (4) 4
patient selection (4) 4
pleural neoplasms - drug therapy (4) 4
pleural neoplasms - therapy (4) 4
retrospective studies (4) 4
reviews (4) 4
thoracoscopy (4) 4
time factors (4) 4
age factors (3) 3
analysis (3) 3
angiogenesis (3) 3
angiogenesis inhibitors - therapeutic use (3) 3
antimitotic agents (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1405 - 1414
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 12/2016, Volume 17, Issue 12, pp. 2132 - 2132
Journal Article
The Lancet Oncology, ISSN 1470-2045, 06/2018, Volume 19, Issue 6, pp. 799 - 811
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 06/2019, Volume 14, Issue 6, pp. 1095 - 1101
Introduction: KRAS mutation is the most frequent molecular alteration found in advanced NSCLC; it is associated with a poor prognosis without available... 
PD-L1 expression | KRAS mutation | NSCLC | Immunotherapy | ONCOLOGY | RESPIRATORY SYSTEM | NIVOLUMAB | DOCETAXEL
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S458 - S459
Journal Article
British Journal of Cancer, ISSN 0007-0920, 06/2017, Volume 116, Issue 12, pp. 1505 - 1512
Journal Article
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, ISSN 1753-4658, 02/2019, Volume 13, p. 1753466619831906
Molecular profiling of metastatic nonsquamous non-small cell lung cancer (NSCLC) is required to guide the treatment strategy. Anaplastic lymphoma kinase (ALK)... 
ALK | non-small cell lung cancer | brain metastases | INHIBITOR ALECTINIB | OPEN-LABEL | ANTITUMOR-ACTIVITY | SINGLE-ARM | CHEMOTHERAPY | alectinib | REARRANGEMENT | RESPIRATORY SYSTEM | CNS METASTASES | CRIZOTINIB | CSF CONCENTRATION | J-ALEX
Journal Article